These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32028398)
1. Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant). Vucic S; Ryder J; Mekhael L; Rd H; Mathers S; Needham M; Dw S; Mc K; Medicine (Baltimore); 2020 Feb; 99(6):e18904. PubMed ID: 32028398 [TBL] [Abstract][Full Text] [Related]
2. Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial. Urbi B; Broadley S; Bedlack R; Russo E; Sabet A BMJ Open; 2019 Nov; 9(11):e029449. PubMed ID: 31719072 [TBL] [Abstract][Full Text] [Related]
3. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS). Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038 [TBL] [Abstract][Full Text] [Related]
4. Study protocol of RESCUE-ALS: A Phase 2, Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT BMJ Open; 2021 Jan; 11(1):e041479. PubMed ID: 33431491 [TBL] [Abstract][Full Text] [Related]
5. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial. Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study. Vucic S; Henderson RD; Mathers S; Needham M; Schultz D; Kiernan MC; Ann Clin Transl Neurol; 2021 Oct; 8(10):1991-1999. PubMed ID: 34477330 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Mandrioli J; D'Amico R; Zucchi E; Gessani A; Fini N; Fasano A; Caponnetto C; Chiò A; Dalla Bella E; Lunetta C; Mazzini L; Marinou K; Sorarù G; de Biasi S; Lo Tartaro D; Pinti M; Cossarizza A; Medicine (Baltimore); 2018 Jun; 97(24):e11119. PubMed ID: 29901635 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. ; Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181 [TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Lombardo FL; Spila Alegiani S; Mayer F; Cipriani M; Lo Giudice M; Ludolph AC; McDermott CJ; Corcia P; Van Damme P; Van den Berg LH; Hardiman O; Nicolini G; Vanacore N; Dickie B; Albanese A; Puopolo M; Trials; 2023 Dec; 24(1):792. PubMed ID: 38053196 [TBL] [Abstract][Full Text] [Related]
12. Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial. Park SB; Vucic S; Cheah BC; Lin CS; Kirby A; Mann KP; Zoing MC; Winhammar J; Kiernan MC EBioMedicine; 2015 Dec; 2(12):1916-22. PubMed ID: 26844270 [TBL] [Abstract][Full Text] [Related]
13. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial. Nam JY; Lee TY; Kim K; Chun S; Kim MS; Shin JH; Sung JJ; Kim BJ; Kim BJ; Oh KW; Kim KS; Kim SH Trials; 2022 May; 23(1):415. PubMed ID: 35585556 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B; Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198 [TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial. Mitsumoto H; Cheung K; Oskarsson B; Andrews HF; Jang GE; Andrews JA; Shah JS; Fernandes JA; McElhiney M; Santella RM Trials; 2023 Jul; 24(1):449. PubMed ID: 37430314 [TBL] [Abstract][Full Text] [Related]